Navigation Links
A Novel Vaccine to Combat Bird Flu in the Pipeline

The novel vaccine that is being formulated by scientists, promises protection against all strains of flu virus. It is expected to be efficient to fight 24 strains// of influenza A virus, that is the cause of outbreaks of both bird flu and winter flu.

Two injections of this vaccine is expected to bestow life long immunity. The only other current option is a vaccine that has to be repeatedly administered every year.

The injection is yet to be tried on humans. The first clinical tests will be tried out by scientists from biotech firm Acambis in Britain and Flanders Interuniversity Institute for Biotechnology in Belgium in the coming months. This vaccine is supposedly easier to manufacture ensuring that vast quantities of the vaccine can be stocked up for prevention of global outbreaks of flu.

Since the strains of influenza virus ,keep on changing frequently, it has been impossible to develop a single vaccine to suit every strain.

The new universal vaccine used in the injections is developed in eggs of hen. This vaccine is aimed on a protein called M2 that hasn’t shown many variations in the last century.
MST
'"/>




Page: 1

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Novel Vaccine Combat Bird Flu the Pipeline

(Date:12/2/2008)...wire-FirstCall/ -- VirtualScopics, Inc.,(Nasdaq: ...ng for clinical,trials, today announced that its ... $14.7 million at the same time a year ago, a grea...klog as the amount remaining to be,recognized fro...e studies,included within the backlog ranges from...
(Date:12/2/2008)...nds Many Cite Prevention, Shedding, or Sharing Cos...e-USNewswire/ -- A New Center for State and Local ...re balancing retiree health care plans and their n...are in the American States examines how state adm...lth care benefits to central human resources (HR) ...
(Date:12/2/2008)...treated with radiation prior to surgery for advanc...currence and better overall survival rates, accord...xamined a treatment called neoadjuvant therapy, wh...pread of cancer, before surgery to remove the tumo...d/or radiation. , Neoadjuvant therapy should no...
(Date:12/2/2008)... from the Institute of Medicine proposes revisions... decrease the chances of fatigue-related medical e...these doctors in training. The report does not re...m the maximum average of 80 per week set by the Ac... (ACGME) in 2003, but rather reduces the maximum n...
Breaking Medicine News(10 mins):Health News:VirtualScopics Backlog Rises to a Record $27 Million 2Health News:VirtualScopics Backlog Rises to a Record $27 Million 3Health News:States View Limits on Retiree Health Benefits 2Health News:Revised hours and workloads for medical residents needed to prevent 2Health News:Revised hours and workloads for medical residents needed to prevent 3
...sday approved Wyeth's oral contraceptive Lybrel, w...riods, the Los Angeles Times reports. Lybrel, whi...a daily dose than traditional oral contraceptives,...The usual regimen for oral contraceptives is 21 ac...
...tter working conditions for nurses are safer for e...ng to a recent report , led by researchers that m...ospital associated infections are the number six c...7). Nurses, as the largest workforce in the nation...
...that obese patients with asthma are more likely to... not overweight . The study was conducted by a te... Holguin and colleagues at Emory University. As p...rchers conducted a survey of more than 3,000 adult...
... who smoke during pregnancy may be exposing their ...ivity disorder (ADHD), according to a study publis...y states that prenatal exposure to smoking in the ...ically susceptible children at an increased risk t...
Other Medicine News:Health News:FDA Approves Wyeth's Oral Contraceptive Lybrel 2Health News:Better Working Conditions for Nurses Might Decrease Patient Infections 2Health News:Better Working Conditions for Nurses Might Decrease Patient Infections 3Health News:Obesity Might Lead to Severe Persistent Asthma Attacks: Study 2
(Date:11/26/2008)...26 Children whose eyes ...tly increased risk of developing mental illness by... Clinic study published this month in Pediatrics ,...ediatrics. , , The retrospective study exam...bismus (misaligned eyes) and compared them with re...
(Date:11/25/2008)...5 Kleinert Kutz and Un...e fifth U.S. hand transplant on Messina, New York ...ish Hospital Hand Care Center on Monday, November ...d was completed shortly after 9 p.m. in a record n....com/cgi-bin/prnh/20081125/DC48555-a ) , (Photo...
(Date:11/25/2008)... 25 Pharmacyclics, Inc.,...y has completed a Phase 1,clinical trial with PCI...-molecule Factor VIIa inhibitor. The trial was con...uate the safety and pharmacologic effect of,PCI-2...d in a linear dose,response in the International ...
(Date:11/24/2008)...24 Domino,s Pizza (NYSE: DPZ ), ... gearing up to raise dough for,the kids of St. Ju...nnual,Thanks and Giving campaign. Domino,s custom...at point of purchase to benefit the children of St...the phone or when ordering online at, www.dominos...
Breaking Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Study fuels debate over whether exercise and body size influence ovarian cancer risk 2180 1Study fuels debate over whether exercise and body size influence ovarian cancer risk 2180 2Study fuels debate over whether exercise and body size influence ovarian cancer risk 2180 3Susan G Komen for the Cure Partners With the Original Butter Bell 28R 29 Crock Developer 2176 1Susan G Komen for the Cure Partners With the Original Butter Bell 28R 29 Crock Developer 2176 2New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 1New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 2New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 3New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 4New Report Says a Pandemic is Overdue But Companies and Nations are ill Prepared to Cope With the Impact 2173 5Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 1Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 2Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 3Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20 25 of Outstanding Shares 2170 4
...s.--(BUSINESS WIRE)--Apr 12, 2007 - CombinatoRx,I...osters related,to its oncology research efforts wi...American Association for Cancer Research,April 14...ng of Targeted Chemical Combinations for,Cancer Th...resented,on Sunday, April 15, 1-5pm PT and "Synerg...
...ion pyridopyrazine-urea derivative compound series... be valuable for,cancer treatment, QUEBEC, April 1...Inc. , a global, pure play biopharmaceutical compa...y presented an abstract,outlining first in vitro d...lectivity for PI3K inhibition, at the American,Ass...
Other Medicine Technology:CombinatoRx to Present Combination High Throughput Screening (cHTS),Data at Upcoming AACR Meeting 2CombinatoRx to Present Combination High Throughput Screening (cHTS),Data at Upcoming AACR Meeting 3AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3
These precision 4mL PYREX volumetric pipets are manufactured and calibrated "To Contain" (TC - bottom line) and "To Deliver" (TD - top line) to specifications for Class A volumetric ware. Pipets are
The new Finnpipette Focus from Thermo Labsystems was designed specifically to combine ergonomics with uncompromising performance. The new interchangeable handle plate offers a custom fit for differe
Inquire
A fixed pipette is ideal for repeated pipetting of a single volume. Fixed volume FInnpipettes offer the same features and advantages as other Finnpipette Digital pipettes: New, streamlined design, S
Medicine Products: